https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-1
Avient
Avient
Avient's
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-7
Avient Corporation
Avient
Avient
https://www.avient.com/investor-center/news/avient-announces-quarterly-dividend-12
Avient
Avient Corporation
Avient Corporation
https://www.avient.com/resource-center/services/avient-color-prediction-service
Achieving Bright, Beautiful, Sustainable Packaging by l'Oréal and Avient
Avient PCR Color Prediction Service - Product Bulletin
Avient's Digital Color Prediction Service for Post-Consumer Recycled Content
https://www.avient.com/company/policies-and-governance/avient-corporation-privacy-statement
Communications from Avient.
Avient Canada ULC
Avient Quality Policy
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
Speed to market is essential today, and Avient plays a crucial role in our customers’
success.
We are Avient.
Avient acquired the Clariant Masterbatch business (CMB) on July 1, 2020 (the “Acquisition Date”).
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
Speed to market is essential today, and Avient plays a crucial role in our customers’
success.
Assess top 90% of supplier spend for alignment
with Avient Sustainability objectives.
We are Avient.
https://www.avient.com/sites/default/files/2020-10/auto-injector-application-study.pdf
Autoinjector Pen - Avient Application Study.mm (1)
AUTO-INJECTOR
APPLICATION STUDY
M A T E R I A L T E C H N O L O G I E S +
S E R V I C E S F O R N E X T
G E N E R A T I O N D E S I G N S
Avient Corporation 1
Avient Corporation 2
Innovating Design
Medical innovations and plastics have gone
hand-in-hand to make healthcare safer, cleaner,
and more accessible for all.
WHY AVIENT?
Avient Corporation 12
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources.
For the same reasons, Avient is unable to address the probable significance of the unavailable information.
Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M.
2023E (%)
27
78
89
83 80 78 74
86
79 76
67 66
55
50
(39)
Av
ie
nt
AV
PM FM
C C
Avient Specialty
Other Specialty /
MULTIPLE EXPANSION
Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources.
Each of such adjustments has not yet occurred, are out of Avient’s control and/or cannot
be reasonably predicted.
For the same reasons, Avient is unable to address the probable significance of the unavailable information.